Companies / Takeda
Takeda
Company- Registered trials
- 1296
- Ongoing
- 177/ 14%
- Completed
- 902
- Related drugs
- 6
- Related conditions
- 11
Clinical trial landscape
1296 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 3 | 352 | 46 | 256 | |
| Unknown | 318 | 62 | 223 | |
| Phase 2 | 204 | 33 | 124 | |
| Phase 1 | 203 | 5 | 165 | |
| Phase 4 | 118 | 12 | 78 | |
| Phase 1/2 | 45 | 11 | 20 | |
| Not applicable | 31 | 5 | 16 | |
| Phase 2/3 | 18 | 3 | 15 | |
| Early Phase 1 | 7 | 0 | 5 | |
| All phases | 1296 | 177 | 902 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.